←
Amgen 🧪🔬🧬14,198 posts
Amgen 🧪🔬🧬 avatar

Amgen 🧪🔬🧬

@Amgen

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases. 🔗 Guidelines: amgen.ly/RpcA3B

◷ Joined April 2009▧ 4,375 Photos and videos
Amgen 🧪🔬🧬 avatar
Amgen 🧪🔬🧬@Amgen·Nov 2

1/2 @Bloomberg went inside Amgen @deCODE genetics in Iceland to get an exclusive look at how Amgen is using human DNA to shape our distinct approach to obesity research: bloomberg.com/news/videos/20… $AMGN

Amgen 🧪🔬🧬 avatar
Amgen 🧪🔬🧬@Amgen·Nov 14

No two obesity journeys look the same, which is why real progress in obesity care starts with listening. At #HLTHUSA, we’re putting that into practice. Watch Amy share her experience and learn why continued dialogue and understanding matter. 🔗 amgen.ly/3Xrlj3N

0:42
Amgen 🧪🔬🧬 avatar
Amgen 🧪🔬🧬@Amgen·Nov 13

At @ACRheum’s #ACR26, researchers, clinicians and community voices surfaced unanswered questions in rare autoimmune and inflammatory diseases. Byeong Yoon explains how those exchanges can guide future research. ▶️

1:19
Amgen 🧪🔬🧬 avatar
Amgen 🧪🔬🧬@Amgen·Nov 12

As we head into #HLTHUSA and #ObesityWeek, one thing is clear: the future of obesity care will be shaped by the conversations we have and actions we take together. By bringing together diverse voices, these meetings create opportunities to address the significant burdens that continue to impact millions of people living with obesity.

0:42
Amgen 🧪🔬🧬 avatar
Amgen 🧪🔬🧬@Amgen·Nov 8

Why do some people develop heart disease while others don’t? Amgen research leader and AHA Population Research Prize recipient Pradeep Natarajan shares insights in a new Q&A article. amgen.ly/4iBF5Ra

Post attachment
Amgen 🧪🔬🧬 avatar
Amgen 🧪🔬🧬@Amgen·Nov 6

B cells are built to protect us. But in autoimmune disease, they can become dysregulated and contribute to disease. Amgen researchers are exploring whether targeting CD19 could help address that🔬

1:35
Amgen 🧪🔬🧬 avatar
Amgen 🧪🔬🧬@Amgen·Nov 5

📢 Amgen’s real-world study shows that treatment decisions to lower LDL-C impacts heart attack risk in ASCVD patients. The findings prompt a closer look at how we approach LDL-C lowering in clinical practice. 🔗 amgen.ly/47Z4v6A $AMGN

0:23
Amgen 🧪🔬🧬 avatar
Amgen 🧪🔬🧬@Amgen·Oct 31

At AHA #ScientificSessions26, Amgen is adding to its extensive base of cardiovascular evidence, with new research exploring LDL-C management, long-term outcomes and the economic considerations of care. Explore our abstracts ⬇️

0:56
Amgen 🧪🔬🧬 avatar
Amgen 🧪🔬🧬@Amgen·Oct 28

Every story is personal. Every voice can help bring our mission into focus. Meet people whose experiences with cancer, cardiovascular disease, rare disease and obesity have shaped their lives and perspectives. At Amgen, serving patients is our mission. We’re honored to be named to @TIME World’s Best Companies 2026 list: amgen.ly/4ipVlEY

Post attachment
Amgen 🧪🔬🧬 avatar
Amgen 🧪🔬🧬@Amgen·Oct 27

Innovation has deep roots in Massachusetts, and Amgen is proud to have been part of its life sciences community for 25 years. From our research center in Cambridge, our teams continue to push the boundaries of science to advance medicines for patients around the world. Learn more about our history in Massachusetts: amgen.ly/4iqQtzr

Post attachment